Skip to content

Evaluation of the Consequences of Poly Vaccination on Innate Immunity : Applications to a Military Population

VaxInnate : Evaluation of the Consequences of Poly Vaccination on Innate Immunity : Applications to a Military Population

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06110741
Acronym
VaxInnate
Enrollment
410
Registered
2023-11-01
Start date
2023-11-30
Completion date
2026-04-30
Last updated
2023-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccine Breakthrough Infections

Brief summary

In this study, the poly vaccination of military personnel prior to deployment will be analyzed in terms of central, peripheral and long-lasting changes in innate immunity. Analysis of monocyte immune training induced by vaccination will provide a better understanding of the indirect effects of vaccination and their persistence over time.

Interventions

Collecting blood and saliva sample

OTHERSurvey

Collecting data on infectious diseases during the study period

Sponsors

Direction Centrale du Service de Santé des Armées
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* french military personnel * \>18yo * overseas deployment scheduled between 30 and 60 days after vaccination session * adult * able to give consent

Exclusion criteria

* unrectified military personnel * having received a live vaccine within 6 months prior to inclusion * having received an attenuated vaccine within 3 months prior to inclusion * pregnancy or breastfeeding * vaccine contraindication * major incapacity

Design outcomes

Primary

MeasureTime frameDescription
Monocytes' functional reprogramming11 monthsdescribing the functional reprogramming of monocytes following vaccination sessions among military personnel prior and after deployment

Secondary

MeasureTime frameDescription
Identify immune signatures11 monthsIdentifying immune signatures by comparing the functional reprogramming of monocytes by different vaccines and co vaccinations schemes
Time persistence11 monthsAssess the persistence over time of the effects by follow-up after return from mission

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026